Beijing Mano Biopharmaceutical Co., Ltd., PuraVation, a subsidiary of Humanwell Pharmaceutical Group, is an enterprise dedicated to the production, research and development of in vitro diagnostic reagents

PuraVation, from the United States, is a high-level professional protective mask customized for dentists and surgeons, introduced to China in 2014, providing more comprehensive, thoughtful, safe and reliable health protection and luxury wearing enjoyment for Chinese consumers who pursue a high-quality life.

Beijing Mano Biopharmaceutical Co., Ltd., located in Yanqi Industrial Development Zone, Huairou City, Beijing, was established in 2005. After 10 years of unremitting efforts, Mano Biotech has witnessed the progress of non-invasive HIV testing in China and contributed to the cause of AIDS prevention and control in China.

The company is committed to the production, research and development of in vitro diagnostic reagents, and its main product "aware" is a non-invasive HIV detection product certified by the CFDA (State Food and Drug Administration) in China as early as 2008. As a pioneer in the non-invasive HIV testing industry, Manol Biotech has a number of patents such as Chinese invention patents, utility model and design patents for saliva HIV detection technology.

The company covers the whole industrial chain of R&D, production and sales, and has a clear business model, which is very different from the traditional reagent industry. It is under the traction of the product positioning of "POCT FMCG Internet" that the sales volume of Mano Biotech has increased year by year, with an annual growth rate of nearly 100%, and the market share of Aiwei is nearly 6%.

Mano Biotech has always adhered to the concept of "quality is life, precision comes from responsibility", insisted on selecting core raw materials from the world's excellent suppliers, and the production workshop has passed the dual certification of ISO 9001 and ISO 13485, with an annual production capacity of 100 million people.